Showing: 1 - 3 of 3 RESULTS

Advanced ICU Care and UAB Medicine Enter Strategic Telemedicine Partnership

ST. LOUIS, Mo., Oct. 13, 2020 /PRNewswire/ — Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine services, announced a large strategic telemedicine partnership with UAB Medicine, a nationally recognized leader in patient care, research and training. The technology, operations, and care partnership encompasses the entire UAB Health System including University of Alabama at Birmingham Hospital, the third largest public hospital facility in the U.S. The relationship initiates with the development of a new tele-ICU operations center in Birmingham and envisions serving up to 750 ICU beds in Alabama and surrounding states.

The new partnership brings together leading healthcare innovators to advance the practice and operational models of tele-ICU care. UAB Medicine’s desire to provide state-of-the-art tele-ICU services for its ICU units led to extensive evaluation of tele-ICU options. Advanced ICU Care has developed unique assets and experience in its fifteen years of offering telemedicine care.

In particular, Advanced ICU Care’s proprietary HUB workflow management software platform uniquely addresses the challenges associated with the customized delivery of acute patient care at high volumes across multiple care venues. In addition, the company’s technical, operational, and clinical expertise draw upon its care of over a half million tele-ICU patients and care partnerships with more than 100 hospitals nationwide. UAB Medicine brings to the relationship additional clinical expertise as a national leader in pulmonary and critical care medicine.

 “Advanced ICU Care’s clinical and operational expertise and proprietary HUB workflow management software are assets that are well aligned with UAB’s vision for our tele-ICU programs,” said Reid Jones, CEO of UAB Medicine. “Telehealth and tele-ICU have become increasingly important vehicles for healthcare delivery, and we look forward to leveraging Advanced ICU Care’s assets to deliver high-acuity telemedicine to patients across Alabama and beyond.”

“The size and scope of this unique tele-ICU services partnership is indicative of the forward looking, innovation-oriented cultures of both organizations,” said Lou Silverman, CEO of Advanced ICU Care. “As a technology-enabled healthcare services organization, we have successfully implemented and managed more tele-ICU programs than any other provider in the nation. We see this partnership as an endorsement of the successes we have achieved to date and as a validation of our vision for the future of telemedicine. We look forward to collaborating closely with the UAB Medicine team in this inspired project.”

About UAB Medicine

UAB Medicine comprises the School of Medicine and the $4.3 billion UAB Health System that includes all of the University of Alabama at Birmingham‘s patient-care activities and 2,300 licensed beds in six hospitals, one of which is UAB Hospital — the third-largest public hospital in the United States, winner of the Women’s Choice award, and one of U.S. News & World Report’s Best Hospitals. UAB, a part of the University of Alabama System, is the state of Alabama’s largest single employer and an internationally renowned research university and academic health center; its professional schools and specialty patient-care programs are consistently ranked among the nation’s top 50. UAB is the

Advanced ICU Care and UAB Medicine Enter Strategic Telemedicine Partnership | Nachricht

ST. LOUIS, Mo., Oct. 13, 2020 /PRNewswire/ — Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine services, announced a large strategic telemedicine partnership with UAB Medicine, a nationally recognized leader in patient care, research and training. The technology, operations, and care partnership encompasses the entire UAB Health System including University of Alabama at Birmingham Hospital, the third largest public hospital facility in the U.S. The relationship initiates with the development of a new tele-ICU operations center in Birmingham and envisions serving up to 750 ICU beds in Alabama and surrounding states.

(PRNewsfoto/Advanced ICU Care)

The new partnership brings together leading healthcare innovators to advance the practice and operational models of tele-ICU care. UAB Medicine’s desire to provide state-of-the-art tele-ICU services for its ICU units led to extensive evaluation of tele-ICU options. Advanced ICU Care has developed unique assets and experience in its fifteen years of offering telemedicine care.

In particular, Advanced ICU Care’s proprietary HUB workflow management software platform uniquely addresses the challenges associated with the customized delivery of acute patient care at high volumes across multiple care venues. In addition, the company’s technical, operational, and clinical expertise draw upon its care of over a half million tele-ICU patients and care partnerships with more than 100 hospitals nationwide. UAB Medicine brings to the relationship additional clinical expertise as a national leader in pulmonary and critical care medicine.

“Advanced ICU Care’s clinical and operational expertise and proprietary HUB workflow management software are assets that are well aligned with UAB’s vision for our tele-ICU programs,” said Reid Jones, CEO of UAB Medicine. “Telehealth and tele-ICU have become increasingly important vehicles for healthcare delivery, and we look forward to leveraging Advanced ICU Care’s assets to deliver high-acuity telemedicine to patients across Alabama and beyond.”

“The size and scope of this unique tele-ICU services partnership is indicative of the forward looking, innovation-oriented cultures of both organizations,” said Lou Silverman, CEO of Advanced ICU Care. “As a technology-enabled healthcare services organization, we have successfully implemented and managed more tele-ICU programs than any other provider in the nation. We see this partnership as an endorsement of the successes we have achieved to date and as a validation of our vision for the future of telemedicine. We look forward to collaborating closely with the UAB Medicine team in this inspired project.”

About UAB Medicine

UAB Medicine comprises the School of Medicine and the $4.3 billion UAB Health System that includes all of the University of Alabama at Birmingham‘s patient-care activities and 2,300 licensed beds in six hospitals, one of which is UAB Hospital — the third-largest public hospital in the United States, winner of the Women’s Choice award, and one of U.S. News & World Report’s Best Hospitals. UAB, a part of the University of Alabama System, is the state of Alabama’s largest single employer and an internationally renowned research university and academic health center; its professional schools and specialty patient-care programs are consistently ranked among the nation’s top 50. UAB is the

UAB doctor who had COVID-19 would advise Trump to ‘go slow’

The treatment President Donald Trump is receiving for COVID-19 is probably the first of its kind and could help him improve quickly. But Dr. Michael Saag, an infectious disease expert at UAB who came down with COVID-19 back in March, would advise the president to “go slow.”

“The symptoms wax and wane, so there will be moments where he will feel pretty good, and he’ll think he’s through it, and then it will come back in a very haunting way 12 hours later,” Saag said. “The people who I see who suffer the most from fatigue are the ones who tried to do too much too quickly. So I would say definitely take it easy for at least the next week. The more he tries to do, the slower his recovery will be from the fatigue.”

Saag, a professor of medicine and infectious diseases at UAB, said much of Trump’s treatment, as gleaned from medical briefings, shows the strides physicians have made in the past six months in fighting coronavirus.

Trump entered Walter Reed Medical Center Friday, with reports emerging later of a spike in fever and fatigue. Doctors revealed that Trump experienced two incidents, on Friday and Saturday, where his oxygen levels dropped.

According to medical briefings, the president has been given the steroid dexamethasone on Saturday, in addition to remdesivir, an antiviral drug. He has also received an experimental antibody cocktail that is being tested by the drug maker Regeneron.

Remdesivir and dexamethasone are drugs that already have a track record of being used with COVID-19 patients, Saag said. The Regneron therapy, however, is new, and Saag said he didn’t know of any other patients who have used it in conjunction with remdesivir and dexamethasone.

To understand how the drugs work, Saag said its important to know how the virus attacks the body. SARS-CoV-2, which causes coronavirus, attacks the body, reproducing “like crazy” within the body and triggering a response from the patient’s immune system. The problem is that the virus complicates the immune system’s ability to “cool down,” causing many of the well-known symptoms – shortness of breath, coughing, fever.

Remdesivir is usually given intravenously for five days, twice-a-day, he said. The Regneron therapy attacks the spike protein of the virus, blocking the ability of the virus to enter cells in the body. Together, the two drugs are meant to keep the virus from replicating.

“To my knowledge, (Trump) is the first person in the world to receive the drugs together,” he said. “That said, it makes perfect sense to choose that approach, even though there is no data to support it.”

Dexamethasone takes on the other problem – that of an overactive immune system.

“After the immune system attacks a virus, it has a way of tapping the brakes and slowing down,” Saag said. “The COVID virus has an almost unique ability to interfere with the immune system’s shutting down. What you end up with, especially in people who get older, there’s an out-of-control immune system